SCHEMBL3562274

SCHEMBL3562274

O=C(O)NCc1cc(F)ccc1F

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.47
CNR1 P21554 1/20 0.46
CHRM4 P08173 1/20 0.45
RAB9A P51151 1/20 0.44
MAPK8 P45983 1/20 0.43
ROCK2 O75116 2/20 0.43
MET P08581 1/20 0.43
ROCK1 Q13464 1/20 0.43
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
RIPK1 Q13546 1/20 0.42
P2RX7 Q99572 2/20 0.41
NAMPT P43490 1/20 0.41
HTR7 P34969 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3568253 0.85 P2RX7 (0.53) ALDH1A1MAPK8METP2RX7
SCHEMBL4511617 0.84 P2RX7 (0.41) ALDH1A1LMNAMAPTCNR1P2RX7
SCHEMBL5810435 0.84 CNR1 (0.45) ALDH1A1LMNAMAPTCNR1CHRM4
SCHEMBL7137210 0.84 MAPK8 (0.49) ALDH1A1LMNAMAPTCNR1CHRM4
SCHEMBL4329517 0.84 CNR1 (0.45) ALDH1A1LMNAMAPTCNR1CHRM4
SCHEMBL4329523 0.84 CNR1 (0.45) ALDH1A1LMNAMAPTCNR1CHRM4
SCHEMBL27787353 0.84 AKR1B1 (0.44) ALDH1A1LMNACHRM4RAB9AMET
SCHEMBL23275529 0.82 AKR1B1 (0.43) ALDH1A1LMNAMAPTRAB9ARIPK1
SCHEMBL20472487 0.82 P2RX7 (0.43) ALDH1A1P2RX7
SCHEMBL2526148 0.82 SETDB1 (0.43) ALDH1A1LMNARAB9AP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166587-B2 Carbamic acid alkyl ester derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-23 US claimed
US-20050075327-A1 Carbamic acid alkyl ester derivatives HOFFMAN-LA ROCHE INC. 2005-04-07 US claimed
EP-1673347-B1 SUBSTITUTED DIBENZO-AZEPINE AND BENZO-DIAZEPINE DERIVATIVES USEFUL AS GAMMA-SECRETASE INHIBITORS HOFFMANN LA ROCHE (CH) 2015-08-19 EP disclosed
US-7671072-B2 Aminopyrazole derivatives as GSK-3 inhibitors PFIZER INC. (US) 2010-03-02 US disclosed
US-20070276010-A1 Aminopyrazole Derivatives as Gsk-3 Inhibitors BENBOW JOHN W 2007-11-29 US disclosed
US-7166587-B2 Carbamic acid alkyl ester derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-23 US disclosed
EP-1673347-A1 SUBSTITUTED DIBENZO-AZEPINE AND BENZO-DIAZEPINE DERIVATIVES USEFUL AS GAMMA-SECRETASE INHIBITORS F. Hoffman-la Roche AG (CH) 2006-06-28 EP disclosed
WO-2005040126-A1 SUBSTITUTED DIBENZO-AZEPINE AND BENZO-DIAZEPINE DERIVATIVES USEFUL AS GAMMA-SECRETASE INHIBITORS F. HOFFMAN-LA ROCHE AG (CH) 2005-05-06 WO disclosed
US-20050075327-A1 Carbamic acid alkyl ester derivatives HOFFMAN-LA ROCHE INC. 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075327-A1 Carbamic acid alkyl ester derivatives BCHE, CHRM1, ADCY7 ALDH1A1 1434/4885LMNA 3445/4885MAPT 344/4885
US-20070276010-A1 Aminopyrazole Derivatives as Gsk-3 Inhibitors GSK3B, GSK3A, GSKIP ALDH1A1 1036/4885LMNA 1974/4885MAPT 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.